CDK Inhibitors and FDA: Approved and Orphan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDK Inhibitors and FDA: Approved and Orphan

Published:2024-04-19 Issue:8 Volume:16 Page:1555
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Cicenas Jonas¹²^ORCID,Simkus Jokubas¹³

Affiliation:

1. MAP Kinase Resource, Bioinformatics, Melchiorstrasse 9, CH-3027 Bern, Switzerland

2. Secondary School “Varnų sala”, Baltupio g. 14, LT-08304 Vilnius, Lithuania

3. Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania

Abstract

The protein kinases are a large family of enzymes which catalyze protein phosphorylation at certain amino acids [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2072-6694/16/8/1555/pdf

Reference45 articles.

1. The protein kinase complement of the human genome;Manning;Science,2002

2. Cicenas, J., Zalyte, E., Bairoch, A., and Gaudet, P. (2018). Kinases and Cancer. Cancers, 10.

3. Signaling--2000 and beyond;Hunter;Cell,2000

4. Roscovitine in cancer and other diseases;Cicenas;Ann. Transl. Med.,2015

5. Li, T., Tang, H.C., and Tsai, K.L. (2023). Unveiling the noncanonical activation mechanism of CDKs: Insights from recent structural studies. Front. Mol. Biosci., 10.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study;Cancers;2024-08-20

2. Inhibitors and PROTACs of CDK2: challenges and opportunities;Expert Opinion on Drug Discovery;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP